Overall survival of patients with cholangiocarcinoma Kaplan Meier plot... | Download Scientific Diagram
Cholangiocarcinoma - "Klatskin's" Tumors of the Bile Duct System - CancerConnect
Comparison of the overall-survival rates between hilar... | Download Scientific Diagram
Can bile duct cancer be cured? Survival rates, remission, and more
Biliary tract cancers: NCDB role in rare malignancy | The Bulletin
Current Oncology | Free Full-Text | A Population-Based Retrospective Study of Biliary Tract Cancers in Alberta, Canada
Cholangiocarcinoma - Bile Duct Cancer - Causes, Symptoms, Treatment
Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: Adjuvant therapy is a favorable prognostic factor
Dual-organ invasion is associated with a lower survival rate than single-organ invasion in distal bile duct cancer: A multicenter study | Scientific Reports
Primary tumor resection improves survival in patients with multifocal intrahepatic cholangiocarcinoma based on a population study | Scientific Reports
Distinct prognosis of biliary tract cancer according to tumor location, stage, and treatment: a population-based study | Scientific Reports
Durvalumab Improves Survival in Bile Duct Cancers - NCI
Adding Nab-Paclitaxel to Standard Care Does Not Improve Outcomes in Biliary Tract Cancers - Cancer Therapy Advisor
Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence | BMC Gastroenterology | Full Text
Radiation therapy for recurrent extrahepatic bile duct cancer | PLOS ONE
The new insight of treatment in Cholangiocarcinoma
Clinicopathological analysis and prognosis of extrahepatic bile duct cancer with a microscopic positive ductal margin - ScienceDirect
Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology
Biliary tract cancers: NCDB role in rare malignancy | The Bulletin
Cholangiocarcinoma | Nature Reviews Disease Primers
SSAT - IMPROVED OVERALL SURVIVAL WITH INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF THE BILE DUCT: ANALYSIS OF A LARGE NATIONAL CANCER REGISTRY
Cancers | Free Full-Text | Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer | NEJM Evidence
Cholangiocarcinoma - Wikipedia
